Orthopedics and General Medical Devices

Format: 2017-01-24
Format: 2017-01-24
January 20, 2017 | 83 Pages | SKU: IRTNTR11491

Overview of the global neurology endoscopy devices market

Technavio’s market research analyst predicts the global neurology endoscopy devices market to grow at a CAGR of over 7% between 2017 and 2021. This market is witnessing the emergence of several neurosurgery technologies, which will modify the delivery paradigm of surgical deliveries. Several manufacturers in the market are also adopting robotic-assisted surgeries to enhance the precision and efficacy. Also, many neuro specialty hospitals are incorporating their operating rooms with neurology endoscopy devices, which aids in performing accurate brain or neurological surgeries. Moreover, the introduction of 3D imaging in endoscopes has not only enhanced the visibility aspects but also has led to the better perception and evaluation of the nerve damage. One of the latest developments in the market is the integration of neurology endoscopes with the surgical devices. Neurology endoscopes are integrated with surgical devices to improve the efficiency of surgeries. Foer instance, NICO came up with the NICO Myriad system, which is an automated disposable resection device that is used during neurology endoscopy. The resection device is used for the resection of craniopharyngiomas, pituitary tumors, colloid cysts, and other neurosurgical disorders.

In terms of geography, the Americas led the global market for neurology endoscopy devices and will continue to maintain its dominance over the forecast period. The US is the major revenue contributing country in the region owing to the availability of better healthcare facilities, surging implementation of


January 20, 2017 | 77 Pages | SKU: IRTNTR11658

Overview of the bio-absorbable stents market

Extensive research carried out by the analysts at Technavio has shown that the global bio-absorbable stents market will witness impressive growth and post a staggering CAGR of close to 41% during the forecast period. The augmented demand for minimally invasive (MI) surgical procedures is one of the primary factors driving this market’s growth. As MI endovascular procedures are performed with minute incisions in the body, it is increasingly being used to treat aortic aneurysm, stenosis, and plaque in the blood vessels of the heart and other vessel walls of peripheral organs. Also, MI procedures offer faster recovery, lesser pain and chances of infection, reduced hospital stay and chances of post-surgical complications. As a result, an increasing number of surgeons prefer MI methods as a procedure for vascular stent implantation. The growing number of patients with cardiovascular diseases (CVDs) like abdominal aortic aneurysm will boost the demand for bio-absorbable stents in the coming years.

In terms of geographical regions, the Americas was the highest revenue contributing region in the global bio-absorbable stents market during 2016 and will continue to lead the market in the coming years. The US accounted for the highest market shares in the region. The increasing adoption of technologically advanced products, as well as the increase in the number of coronary and peripheral procedures in the US,  will contribute to the growth of this market in the


January 12, 2017 | 85 Pages | SKU: IRTNTR11144

Overview of the global anesthesia drugs market

The global anesthesia drugs market is anticipated to grow at a steady rate and will post a CAGR of more than 3% during the forecast period. The growing volume of surgical procedures will drive the growth prospects for the global anesthesia drugs market in the coming years. Anesthesia is administered during various surgical procedures conducted to treat various diseases such as cardiovascular diseases, gastrointestinal diseases, urological disorders, spinal abnormalities, brain tumors, and orthopedic deformities. The rise in the number of surgical procedures in the European countries will aid in the growth of the market in these locations. For instance, the number of laparoscopic colectomy procedures doubled in Slovenia and tripled in Spain between 2008 and 2014.  Some of the surgeries performed in various ambulatory surgical centers (ASCs) include lens and cataract, hernia procedure, cervix and uterus removal, hysterectomy, and transurethral excision.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market until the end of 2021. One of the major factors responsible for the market’s growth in the US is the growing demand for propofol. Additionally, the increasing focus of a large number of vendors towards exploring new routes of administration such as oral and topical will also drive the preference for anesthetic drugs in the market. Analysts predict that the increasing demand for anesthesia in labor will also drive market growth. According to the Centers for Disease Control and Prevention (CDC), the total number of deliveries including vaginal and caesarean stood at 3,984,


January 11, 2017 | 70 Pages | SKU: IRTNTR11103

Overview of the interventional spine devices market in the US

Technavio’s market research analyst predicts the interventional spine devices market in the US to grow steadily at a CAGR of above 8% by 2021. One of the primary drivers for this market is the rise in the incidence of spine and bone disorders. The most common spinal disorders include spondylolisthesis, DDC, herniated discs, prolapsed intervertebral disc, and spinal stenosis. Also, osteoporosis can cause degenerative changes in the spinal discs including intervertebral discs and spinal facets that require surgical intervention. This bone disorder can increase bone porosity, fragility, and make bones weaker, making them susceptible to fractures. Interventional procedures help reduce pain, improve bone stability, and increase life expectancy. The growing incidences of spine and bone disorders will drive the adoption of interventional spine procedures during the forecast period.

One of the latest trends gaining traction in this market is the shift in physician preference for minimally invasive (MI) procedures. The advancements in spinal interventions has led to an increase in the number of clinical trials and launch of new products in the market. The demand for rapid recovery reduced hospital stays, and better patient outcome resulted in many medical facilities conducting spinal fusion surgery to repair the vertebrae and treat painful conditions of the spine. Moreover, owing to its increased ability to treat spinal disorders such as spinal tumors,


January 10, 2017 | 114 Pages | SKU: IRTNTR11470

Overview of the global interventional spine devices market

Technavio’s market research analyst predicts the global interventional spine devices market to grow steadily at a CAGR of above 10% by 2021. One of the key factors responsible for this market growth is the increasing number of incidences of spine and bone disorders. There has been a significant rise in the incidence of spinal disorders across the world over the last decade. The most common spinal disorders include spondylolisthesis, degenerative disc disease, herniated discs, prolapsed intervertebral disc, and spinal stenosis. Disc herniation is a result of age-related degeneration of the annulus fibrosis or trauma, lifting injuries, or straining. Also, osteoporosis can lead to degenerative changes in the spinal discs, including intervertebral discs and spinal facets that require surgical intervention.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. Owing to the widespread adoption of minimally invasive and non-invasive techniques the Americas is dominating the interventional spine devices market. The US is the largest revenue contributor to this region due to the increased use of interventional spine surgery. Other major growth drivers for the Americas include the existence of transparent reimbursement policies, high disposable incomes, and high awareness about vertebral compression fracture


December 13, 2016 | 76 Pages | SKU: IRTNTR11109

Overview of the global laparotomy sponges market

The global laparotomy sponges market is anticipated to grow at a steady rate and will post a CAGR of close to 8% during the forecast period.  Growing advancements in technology to perform abdominal laparotomy procedures will drive the growth prospects for the global laparotomy sponges market until the end of 2020. These technological advancements will allow both vendors and the healthcare providers to address healthcare challenges such as sterilization and access to affordable healthcare services, which results in the development of efficient products. For instance, the laparotomy sponges labeled with RFID tags helps reduce the retention of sponges and improve the quality of the operation. In addition, the market analysis also shows that products such as sterile laparotomy sponge ensure enhanced safety from infective agents. For instance, Medical Action Industries developed X-ray detectable laparotomy sponges that have a high quality and reliability by incorporating advanced and modern systems to provide sterile laparotomy sponges. Similarly, Stryker recently introduced the SurgiCount sponge system, which helps to avoid the retainment of surgical sponges in the body.

The growing focus on developing economies will drive the growth prospects for the global laparotomy sponges market for the next four years. One of the major factors contributing to market opportunities for these vendors in emerging economies such as India, China, Africa, and the Middle East is the presence of a huge customer base and high demand. Also, the growing demand for lap sponges fosters its growth prospects across the medical devices and textile industry.

Competitive landscape and key vendors

The global laparotomy sponges market is highly fragmented and


Pages